Cereno Scientific AB (publ) (OM: CRNO B)
Health Care · Biotechnology · SE
Skr0.27
-83.49% today · -96.1% 1Y
Public summary
A free snapshot of Cereno Scientific AB (publ), with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Cereno Scientific AB (publ) (OM: CRNO B) operates in the Biotechnology industry within the Health Care sector. The company is valued at $8.67M.
Over the last twelve months the share price has lost 96.1%, trading between 0.27 and 8.92.
Tweenvest scores Cereno Scientific AB (publ) across four factors: quality 46/100, value 36/100, growth 60/100. Its strongest factor is growth.
CRNO B price history
Key figures
- Market cap
- $8.67M
- Revenue (TTM)
- $-32.53K
- P/E
- -0.65
- EPS
- -0.41
- Dividend yield
- —
- Beta (5Y)
- -0.23
- 52-week high
- Skr8.92
- 52-week low
- Skr0.27
- Avg volume (3M)
- —
- Shares outstanding
- 323.85M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| 1nKemia IUCT Group, S.A.BME: IKM | $8.80M | €0.31 | 0.00% |
| Radiopharm Theranostics LimitedASX: RAD | $8.79M | AU$0.00 | -25.00% |
| Patrys LimitedASX: PAB | $8.75M | AU$0.02 | -2.17% |
| Intensity Therapeutics, Inc.NasdaqCM: INTS | $8.72M | $2.64 | -1.12% |
| CRISM Therapeutics CorporationAIM: CRTX | $8.64M | £0.08 | 0.00% |
| Phio Pharmaceuticals Corp.NasdaqCM: PHIO | $8.57M | $0.72 | -4.65% |
| Regentis Biomaterials Ltd.NYSEAM: RGNT | $8.57M | $1.22 | +2.52% |
| MetaVia Inc.NasdaqCM: MTVA | $8.56M | $1.30 | 0.00% |